Origins
The Soviet biochemistry programs that isolated the original short peptide bioregulators and established the foundational hypothesis of endogenous regulatory pool restoration.
Isolation and the foundational hypothesis.
The earliest era of the lineage was occupied by the painstaking biochemical work of isolating regulatory peptides from animal tissue extracts — primarily pineal gland, thymus, and other endocrine tissues. Initial characterization revealed that these peptides were unusually short (most under ten amino acids), acted in nanomolar concentrations, and demonstrated tissue-specific biological activity at doses that defied conventional receptor-pharmacology expectations.
From this characterization emerged the foundational hypothesis of the lineage: that endogenous regulatory peptide pools, decreasing with age and organ-specific dysregulation, could be replenished therapeutically through structurally-identical synthetic analogs — restoring tissue-specific regulatory function rather than overriding it.
Pre-molecular biology, post-classical pharmacology.
The era preceded the modern molecular-biology toolkit — chromatin immunoprecipitation, transcriptomics, and structural-biology methods that would later resolve the bioregulator mechanism. Characterization in this period was therefore predominantly biochemical, pharmacological, and observational, with the mechanistic resolution to come decades later.
What this era established was the empirical phenomenon: that short peptides administered to mammalian systems produced consistent, tissue-specific, dose-appropriate biological effects across multiple organ systems. The mechanism would come later. The phenomenon was anchored.